Last reviewed · How we verify
ATeGe-Fresenius
ATeGe-Fresenius is a Fresenius medical device used for renal replacement therapy.
ATeGe-Fresenius is a Fresenius medical device used for renal replacement therapy. Used for Renal replacement therapy for patients with end-stage renal disease.
At a glance
| Generic name | ATeGe-Fresenius |
|---|---|
| Sponsor | Hospital Vall d'Hebron |
| Modality | Small molecule |
| Therapeutic area | Nephrology |
| Phase | Phase 3 |
Mechanism of action
It is a type of hemodialysis machine designed to provide efficient and effective treatment for patients with end-stage renal disease. The device uses a combination of filtration and diffusion to remove waste products and excess fluids from the blood.
Approved indications
- Renal replacement therapy for patients with end-stage renal disease
Common side effects
- Hypotension
- Infection
- Air embolism
Key clinical trials
- Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction (PHASE3)
- Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |